This report elaborates the market size, market characteristics, and market growth of the Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs industry, and breaks down according to the type, application, and consumption area of Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market covered in Chapter 13:
Salix Pharmaceuticals Ltd
GlaxoSmithKline
Pfizer
Astellas Pharmaceuticals
Actavis
AstraZenenca

In Chapter 6, on the basis of types, the Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2015 to 2025 is primarily split into:
Preface
Eluxadoline
Alosetron
Rifaximin
Loperamide
Diphenoxylate + Atropine
Dicyclomine and Hyoscyamine

In Chapter 7, on the basis of applications, the Irritable Bowel Syndrome With Diarrhea (Ibs-D) Drugs market from 2015 to 2025 covers:
Hospitals
Clinics
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025